Epileptiform Potential of Fully Immersive Virtual Reality

Status

Not yet recruiting

Phases

Unknown

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT07451093

Enrollment

Registered

2026-03-05

Start date

2026-12-01

Completion date

2027-06-01

Last updated

2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy, Seizure

Keywords

Epilepsy, Seizure, Virtual Reality, VR, Reflex epilepsy

Brief summary

The goal of this interventional study is to determine if the use of virtual reality headsets results in an increased risk of seizure in adolescent and adult individuals with epilepsy. The main question it aims to answer are: \- does use of virtual reality headsets with hand controllers result in a higher risk of seizure compared to use of virtual reality headsets without hand controllers Participants will be asked to wear a virtual reality headset during continuous video EEG recording and EEG with be evaluated during three phases: with display turned off, with display turned on without hand controllers, and with display turned on with hand controllers.

Interventions

OTHERVirtual Reality Headset, display off

15 minutes of EEG recording with VR headset worn, display turned off. This will act as a baseline for intervention 2 and 3

OTHERVirtual Reality Headset, Display only

15 minutes of EEG recording with VR headset worn, display turned on without access to hand controls.

OTHERVirtual Reality Headset, Display and Hand Control

15 minutes of EEG recording with VR headset worn, display turned on with access to hand controls

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

13 Years to No maximum

Healthy volunteers

Inclusion criteria

* subjects with known or suspected diagnosis of epilepsy with interictal epileptiform discharges seen during current or prior EEG recording * Age greater than or equal to 13 years

Exclusion criteria

* Age less than 13 years (infants, children) * Pregnancy * Incarceration * Moderate-severe cognitive impairment

Design outcomes

Primary

Measure	Time frame	Description
Change in prevalence of interictal epileptiform discharges	Three sessions, 15 minutes each	Interictal epileptiform discharges are counted by two epilepsy trained neurologists. Number of discharges seen are compared between each intervention.

Countries

United States

Contacts

CONTACTJared E Quast, MD

jared.e.quast@hitchcock.org6033505104

PRINCIPAL_INVESTIGATORJared E Quast, MD

Dartmouth-Hitchcock Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026